Drugs for Hemiplegia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 43)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Baclofen |
Approved |
Phase 4 |
|
1134-47-0 |
2284 |
Synonyms:
(+-)-Baclofen
4-Amino-3-(4-chlorophenyl)butyrate
4-Amino-3-(4-chlorophenyl)butyric acid
Alphapharm brand OF baclofen
apo Baclofen
apo-Baclofen
ApoBaclofen
Apotex brand OF baclofen
Ashbourne brand OF baclofen
ASTA medica brand OF baclofen
Athena brand OF baclofen
Atrofen
AWD, baclofen
b-(4-Chlorophenyl)gaba
b-(Aminomethyl)-4-chlorobenzenepropanoate
b-(Aminomethyl)-4-chlorobenzenepropanoic acid
b-(Aminomethyl)-p-chlorohydrocinnamate
b-(Aminomethyl)-p-chlorohydrocinnamic acid
b-(p-Chlorophenyl)-g-aminobutyrate
b-(p-Chlorophenyl)-g-aminobutyric acid
BA-34647
BACLOFEN
Baclofen alphapharm brand
Baclofen apotex brand
Baclofen ashbourne brand
Baclofen athena brand
Baclofen awd
Baclofen ciba-geigy brand
Baclofen irex brand
Baclofen isis brand
Baclofen medtronic brand
Baclofen novartis brand
Baclofen nu-pharm brand
Baclofen pharmascience brand
Baclofene
Baclofène
Baclofène irex
Baclofène-irex
BaclofèneIrex
Baclofeno
Baclofenum
Baclon®|Kemstro®|Lioresal®
Baclophen
Baclospas
BACLOSPAS-10
beta-(4-Chlorophenyl)gaba
beta-(Aminomethyl)-4-chlorobenzenepropanoate
beta-(Aminomethyl)-4-chlorobenzenepropanoic acid
beta-(Aminomethyl)-p-chlorohydrocinnamate
beta-(Aminomethyl)-p-chlorohydrocinnamic acid
|
beta-(p-Chlorophenyl)-gamma-aminobutyrate
beta-(p-Chlorophenyl)-gamma-aminobutyric acid
Chlorophenyl gaba
Ciba geigy brand OF baclofen
CIBA34,647ba
CIBA-34,647-ba
Ciba-geigy brand OF baclofen
Clofen
DL-4-Amino-3-p-chlorophenylbutanoate
DL-4-Amino-3-p-chlorophenylbutanoic acid
DL-Baclofen
GABA, chlorophenyl
GABLOFEN
g-Amino-b-(p-chlorophenyl)butyrate
g-Amino-b-(p-chlorophenyl)butyric acid
gamma-Amino-beta-(p-chlorophenyl)butyrate
gamma-Amino-beta-(p-chlorophenyl)butyric acid
Gen baclofen
Gen-baclofen
GenBaclofen
Genpharm
Irex brand OF baclofen
Isis brand OF baclofen
Kemstro
Lebic
Lioresal
LIORESAL INTRATH
LYFLEX
Medtronic brand OF baclofen
Novartis brand OF baclofen
Nu baclo
Nu pharm brand OF baclofen
Nu-baclo
NuBaclo
Nu-pharm brand OF baclofen
PCP-GABA
Pharmascience brand OF baclofen
PMS Baclofen
PMSBaclofen
PMS-Baclofen
Î’-(4-chlorophenyl)gaba
Î’-(aminomethyl)-4-chlorobenzenepropanoate
Î’-(aminomethyl)-4-chlorobenzenepropanoic acid
Î’-(aminomethyl)-p-chlorohydrocinnamate
Î’-(aminomethyl)-p-chlorohydrocinnamic acid
Β-(p-chlorophenyl)-γ-aminobutyrate
Β-(p-chlorophenyl)-γ-aminobutyric acid
Γ-amino-β-(p-chlorophenyl)butyrate
Γ-amino-β-(p-chlorophenyl)butyric acid
|
|
2 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
3 |
|
Betamethasone |
Approved, Vet_approved |
Phase 4 |
|
378-44-9 |
9782 |
Synonyms:
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16b-Methyl-1,4-pregnadiene-9a-fluoro-11b,17a,21-triol-3,20-dione
16Β-methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
9a-Fluoro-16b-methylprednisolone
9alpha-Fluoro-16beta-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16b-methylprednisolone
9-Fluoro-16β-methylprednisolone
9Α-fluoro-16β-methylprednisolone
ALPHATREX
BESAMESTAZONA
Betadexamethasone
Betametasona
BETAMETHASONE
Bétaméthasone
beta-Methasone alcohol
Betamethasonum
BETAMETHASONVALERAT MIKRON
BETASOLAN
|
BETATREX
BETA-VAL
BETNELAN
b-Methasone alcohol
Celeston
Celestona
Celestone
Cellestoderm
DERMABET
Flubenisolone
LOTRISONE
NSC-39470
Rinderon
SCH-4831
TACLONEX
UTICORT
VISUBETA
Î’-methasone alcohol
|
|
4 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
5 |
|
GABA Agonists |
|
Phase 4 |
|
|
|
6 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
7 |
|
Betamethasone-17,21-dipropionate |
|
Phase 4 |
|
|
|
8 |
|
Betamethasone Valerate |
|
Phase 4 |
|
2152-44-5 |
|
Synonyms:
AUDAVATE
AUDAVATE RD
BETACAP
BETADERM
BETAMETH VAL 0.1% 50% IN EMULSIF
BETAMETH VAL IN COAL TAR
BETAMETH VAL OINT 0.1% 25%COAL TAR
BETAMETH VAL OINT 0.1% 50% COALTAR
BETAMETH VAL OINT0.025% 50%COALTAR
BETAMETHASONE 17-VALERATE
BETAMETHASONE VALERATE
BETATREX
BETA-VAL
|
BETESIL
BETNOVATE RD
BETNOVATE-C
BETNOVATE-N
BETTAMOUSSE
BEXTASOL
DERMABET
FUCIBET
LUXIQ
VALISONE
VALNAC
XEMACORT
|
|
9 |
|
Betamethasone sodium phosphate |
|
Phase 4 |
|
|
|
Synonyms:
BETAMETHASONE 21-PHOSPHATE DISODIUM SALT
BETAMETHASONE SODIUM PHOSPHATE
BETAM-OPHTAL
BETNESOL
BETNESOL-N
|
CELESTONE
NSC-90616
VISTAMETHASONE
VISTAMETHASONE N
|
|
10 |
|
Betamethasone benzoate |
|
Phase 4 |
|
|
|
Synonyms:
BETAMETHASONE BENZOATE
UTICORT
|
|
|
11 |
|
abobotulinumtoxinA |
|
Phase 4 |
|
|
|
Synonyms:
ABOBOTULINUMTOXINA
BONT/A
BONTOXILYSIN A
BOTOX
BOTULINUM TOXIN TYPE A
|
BOTULINUM TOXINS, TYPE A
BOTULOTOXIN A
BTX-A
ONABOTULINUMTOXINA
|
|
12 |
|
Botulinum Toxins, Type A |
|
Phase 4 |
|
|
|
13 |
|
Botulinum Toxins |
|
Phase 4 |
|
|
|
14 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
15 |
|
Sodium oxybate |
Approved |
Phase 1, Phase 2 |
|
502-85-2 |
23663870 |
Synonyms:
.GAMMA.-HYDROXYBUTYRATE SODIUM SALT
NSC-84223
OXYBATE SODIUM
SODIUM OXYBATE
|
SODIUM OXYBUTYRATE
WY-3478
XYREM
|
|
16 |
|
Glycerin |
Approved, Investigational |
Phase 2 |
|
56-81-5 |
753 |
Synonyms:
(2,5-Dihydroxyphenyl)-acetate
(2,5-Dihydroxyphenyl)-acetic acid
(2E)-2-Butenedioate
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-But-2-enedioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
1,2,3-Propanetriol
1,2,3-Trihydroxypropane
2-(3,6-DIHYDROXYPHENYL)acetate
2-(3,6-DIHYDROXYPHENYL)acetIC ACID
2-(e)-Butenedioate
2-(e)-Butenedioic acid
2,5-Dihydroxy-alpha-toluate
2,5-Dihydroxy-alpha-toluic acid
2,5-Dihydroxy-a-toluate
2,5-Dihydroxy-a-toluic acid
2,5-Dihydroxy-benzeneacetate
2,5-Dihydroxy-benzeneacetic acid
2,5-Dihydroxyphenylacetate
2,5-Dihydroxyphenylacetic acid
Acid, homogentisic
Alcapton
Allomaleate
Allomaleic acid
alpha-delta-Glucopyranuronic acid
alpha-delta-Glucuronic acid
alpha-D-Glucopyranuronic acid
alpha-D-Glucuronic acid
Ammonium fumarate
Boletate
Boletic acid
Bulbold
Concentrated glycerin
Cristal
D-(+)-Glucuronate
D-(+)-Glucuronic acid
delta-(+)-Glucuronate
delta-(+)-Glucuronic acid
delta-Glucuronate
D-Glucuronate
e 422
e297
Emery 916
FC 33
Fumarate
Fumarsaeure
Furamag
GCU
GlcAa
GlcAalpha
|
Glucosiduronate
Glucosiduronic acid
Glucuronate
Glucuronic acid
Glyceol opthalgan
Glycerin
Glycerin, anhydrous
Glycerin, concentrated
Glycerin,anhydrous
Glycerine
glycérine
Glycerinum
Glyceritol
Glycerol
glycérol
Glycerolum
Glycyl alcohol
Glyrol
Glysanin
Glyzerin
Gro
Homogentisate
Homogentisate acid
Homogentisinate
Homogentisinic acid
IFP
Incorporation factor
Lichenate
Lichenic acid
Mackstat H 66
Mafusol
Magnesium fumarate
Melanic acid
Monoctanoin component D
Oelsuess
Ölsüß
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Sodium fumarate
trans-1,2-Ethylenedicarboxylate
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
Trihydroxypropane
Tryhydroxypropane
|
|
17 |
|
Carbon Fiber |
|
Phase 1, Phase 2 |
|
|
|
18 |
|
Anesthetics, Intravenous |
|
Phase 1, Phase 2 |
|
|
|
19 |
|
Anesthetics, General |
|
Phase 1, Phase 2 |
|
|
|
20 |
|
Protective Agents |
|
Phase 2 |
|
|
|
21 |
|
Benzocaine |
Approved, Investigational |
|
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
22 |
|
Tannic acid |
Approved |
|
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
23 |
|
Raspberry |
Approved |
|
|
|
|
24 |
|
Frovatriptan |
Approved, Investigational |
|
|
158747-02-5 |
77992 |
Synonyms:
(+)-(R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate
3-Methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole
Allegro
Allergo filmtabletten
Frova
Frova®|SB-209509-AX|VML-251
FROVATRIPTAN
|
Frovatriptan succinate
Frovelan
MIGARD
MYLATRIP
SB-209509-AX
VML-251
|
|
25 |
|
Bupivacaine |
Approved, Investigational |
|
|
2180-92-9, 38396-39-3 |
2474 |
Synonyms:
(+-)-Bupivacaine
(±)-bupivacaine
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
Abbott brand OF bupivacaine hydrochloride
ANEKAIN
Anhydrous, bupivacaine
Astra brand OF bupivacaine hydrochloride
AstraZeneca brand OF bupivacaine hydrochloride
Aventis brand OF bupivacaine hydrochloride
Bloqueina
Braun brand OF bupivacaine hydrochloride
Braun, bupivacaina
Bucaine
Bupivacain janapharm
Bupivacain RPR
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaina braun
BUPIVACAINE
Bupivacaine anhydrous
Bupivacaine carbonate
Bupivacaine HCL
Bupivacaine HCL kit
Bupivacaine hydrochloride
Bupivacaine monohydrochloride, monohydrate
Bupivacain-RPR
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
Buvacaina
|
Carbonate, bupivacaine
Carbostesin
CBupivacaine
Chirocaine
DepoBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
DL-Bupivacaine|Exparel®|Marcain®|Posimir®|Sensorcaine®|W-7|Xaracoll®
Dolanaest
DUR-843
Exparel
Hydrochloride, bupivacaine
Inibsa brand OF bupivacaine hydrochloride
Janapharm, bupivacain
Jenapharm brand OF bupivacaine hydrochloride
LAC-43
LIQ865
LIQ-865
Marcain
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
Pisa brand OF bupivacaine hydrochloride
Racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SKY-0402
Strathmann brand OF bupivacaine hydrochloride
Svedocain sin vasoconstr
Transdur-Bupivacaine
|
|
26 |
|
Sodium citrate |
Approved, Investigational |
|
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
27 |
|
Ethanol |
Approved |
|
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
28 |
|
Ropivacaine |
Approved |
|
|
84057-95-4 |
71273 175805 |
Synonyms:
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
(-)-1-Propyl-2',6'-pipecoloxylidide
(+-)-Ropivacaine
(S)-(-)-1-Propyl-2',6'-pipecoloxylidide
(S)-(−)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE
(S)-ROPIVACAINE
1 Propyl 2',6' pipecoloxylidide
1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
1-Propyl-2',6'-pipecoloxylidide
1-propyl-2',6'-pipecoloxylidide|AL-381|LEA-103|Naropin®|ropivacaine hydrochloride
AL-381
DL-Ropivacaine
LEA 103
LEA-103
L-N-N-Propylpipecolate-2,6-xylidide
L-N-N-Propylpipecolic acid-2,6-xylidide
Naropeine
|
Naropin
N-N-Propylpipecolate-2,6-xylidide
N-N-Propylpipecolic acid-2,6-xylidide
Racemic ropivacaine
rac-Ropivacaine
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
Ropivacaine monohydrochloride, (S)-isomer
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
|
|
29 |
|
Flumazenil |
Approved |
|
|
78755-81-4 |
3373 |
Synonyms:
[<sup>11</sup>C]flumazenil (PET ligand)
Anexate
Anexate®|Ro15-1788
Anexic acid
FLUMAZENIL
Flumazenilo
Flumazenilum
Flumazepil
Hoffman la roche brand OF flumazenil
Hoffman-la roche brand OF flumazenil
|
Lanexat
MAZICON
RO15-1788
RO-151788
RO-15-1788
RO-151788000
RO-1722
RO-41-8157
Roche brand OF flumazenil
Romazicon
|
|
30 |
|
gamma-Aminobutyric acid |
Approved, Investigational |
|
|
56-12-2 |
119 |
Synonyms:
γ-amino butyric acid|4-aminobutyric acid|gamma-aminobutyric acid
.GAMMA.-AMINOBUTYRIC ACID
3-Carboxypropylamine
4 Aminobutanoic acid
4 Aminobutyric acid
4Abu
4-Aminobutanoate
4-Amino-butanoate
4-Aminobutanoic acid
4-Aminobutyrate
4-Aminobutyric acid
Acid, hydrochloride gamma-aminobutyric
Aminalon
Aminalone
AMINOBUTYRIC ACID
GABA
GABA, lithium
Gaballon
Gamarex
g-Aminobutanoate
g-AMINO-butanoate
g-Aminobutanoic acid
g-AMINO-butanoic acid
g-Aminobuttersaeure
g-Aminobutyrate
g-Aminobutyric acid
g-Amino-N-butyrate
g-Amino-N-butyric acid
gamma Aminobutyrate
gamma Aminobutyric acid
gamma Aminobutyric acid, hydrochloride
gamma Aminobutyric acid, monolithium salt
gamma Aminobutyric acid, monosodium salt
gamma-Aminobutanoate
gamma-AMINO-butanoate
gamma-Aminobutanoic acid
GAMMA-AMINO-butanoIC ACID
gamma-Aminobuttersaeure
|
gamma-Aminobutyrate
gamma-Aminobutyric acid
gamma-Aminobutyric acid, calcium salt (2:1)
gamma-Aminobutyric acid, hydrochloride
gamma-Aminobutyric acid, monolithium salt
gamma-Aminobutyric acid, monosodium salt
gamma-Aminobutyric acid, zinc salt (2:1)
gamma-Amino-N-butyrate
gamma-Amino-N-butyric acid
Gammalon
Gammalone
Gammar
Gammasol
Hydrochloride gamma-aminobutyric acid
Lithium gaba
Mielogen
Mielomade
NSC-27418
Omega-aminobutyrate
Omega-aminobutyric acid
Piperidate
Piperidic acid
Piperidinate
Piperidinic acid
W-Aminobutyrate
W-Aminobutyric acid
Γ-aminobutanoate
Γ-amino-butanoate
Γ-aminobutanoic acid
Γ-amino-butanoic acid
Γ-aminobuttersaeure
γ-Aminobuttersäure
Γ-aminobutyrate
Γ-aminobutyric acid
Γ-amino-N-butyrate
Γ-amino-N-butyric acid
ω-aminobutyric acid
|
|
31 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
|
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
32 |
|
Melatonin |
Approved, Nutraceutical, Vet_approved |
|
|
73-31-4 |
896 |
Synonyms:
[<sup>3</sup>H]-melatonin|[<sup>3</sup>H]MLT
{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} acetamide
{N-[2-(5-methoxyindol-3-yl)ethyl]-} acetamide
3-(2-Acetamidoethyl)-5-methoxyindole
5-Methoxy-N-acetyltryptamine
BCI-049
Circadin
Circadin®|MLT
GENERAL NUTRIT
HEALTH AID
HEIDADOUPPI
ICENIA
J5.258B
LIFE EXT
MELAPURE
Melatol
Melatonin
Melatonin (synth.) standard-grade
Melatonin (synth.) ultra-pure
Melatonina
Melatonine
Mélatonine
Melovine
MLT
|
MT6
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]-acetamide
N-Acetyl-5-methoxytryptamine
N-Acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxy-tryptamine melatonine
NATROL
NATURE'S BLEND
NATURES BOUNTY
NSC-113928
NSC-56423
QUALITY HEALTH
Regulin
S.GARD
TRAVELAG
VESPRO
VYTALONIN
|
|
33 |
|
Serotonin Receptor Agonists |
|
|
|
|
|
34 |
|
Anti-Arrhythmia Agents |
|
|
|
|
|
35 |
|
Sodium Channel Blockers |
|
|
|
|
|
36 |
|
Diuretics, Potassium Sparing |
|
|
|
|
|
37 |
|
Citrate |
|
|
|
|
|
38 |
|
incobotulinumtoxinA |
|
|
|
|
|
Synonyms:
|
39 |
|
Antioxidants |
|
|
|
|
|
40 |
|
Anesthetics |
|
|
|
|
|
41 |
|
Anesthetics, Local |
|
|
|
|
|
42 |
|
Neurotransmitter Agents |
|
|
|
|
|
43 |
|
Serotonin |
Investigational, Nutraceutical |
|
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
Interventional clinical trials:
(show top 50)
(show all 223)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Functional Electrical Stimulation (FES)-Assisted Walking: Enhancement of Voluntary Walking Function Among Persons With Severe Hemiplegia Post-Stroke |
Unknown status |
NCT00552916 |
Phase 4 |
|
2 |
Doctor, Physical Medicine and Rehabilitation |
Completed |
NCT03860662 |
Phase 4 |
Botox;Baclofen |
3 |
Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients With Hemiplegic Shoulder Pain. |
Recruiting |
NCT05260125 |
Phase 4 |
Ultrasound-guided Suprascapular Nerve Block;Anatomical Landmark-guided Suprascapular Nerve Block |
4 |
Comparison of the Efficacy of 2 Different Botulinum Toxin Injection Techniques in Gastrocnemius Muscle Spasticity in Hemiplegic Patients: A Randomized Double-blind Controlled Study. |
Not yet recruiting |
NCT05615987 |
Phase 4 |
Onabotulinumtoxina for Injection |
5 |
Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After Stroke |
Unknown status |
NCT00276185 |
Phase 3 |
Time delay treatment of botulinum toxin |
6 |
Randomised Controlled Trial to Evaluate the Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity (Repeated Botulinum Toxin Injections and Physiotherapy) on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke |
Unknown status |
NCT02944929 |
Phase 3 |
|
7 |
Evaluation of the Efficacy of "MEOPA" Used to Obtain Better ROM Immediately After Multilevel Surgery in Children With Spastic Diplegia, Quadriplegia or Hemiplegia. |
Completed |
NCT00632528 |
Phase 3 |
MEOPA;Medicinal air |
8 |
Burke-Hocoma Efficiency Study |
Completed |
NCT03555825 |
Phase 3 |
|
9 |
Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical Trial |
Completed |
NCT00223808 |
Phase 3 |
|
10 |
Is it Possible to Improve Static and Dynamic Postural Stability in Cerebral Palsy Children by Modulating Attention? |
Completed |
NCT01799304 |
Phase 3 |
|
11 |
Effects of the Quantity of Repetitive Transcranial Magnetic Stimulation on the Recovery of Upper Motor Function After Stroke: a Randomized Controlled Trial |
Terminated |
NCT01311271 |
Phase 2, Phase 3 |
|
12 |
Effet de la réadaptation Sur Les déficiences, Limitations d'activité et Restriction de la Participation Des Enfants présentant Des lésions Neurologiques Non-évolutives (Infirmes Moteurs cérébraux). |
Unknown status |
NCT01700777 |
Phase 1, Phase 2 |
|
13 |
Rehabilitation of Early Stroke Patients Using a Custom-made Solid Ankle-foot Orthosis: a Randomised Controlled Trial |
Unknown status |
NCT01006772 |
Phase 1, Phase 2 |
|
14 |
Use of Tendon Vibration and Mirror for the Improvement of Upper Limb Function and Pain Reduction After Stroke |
Unknown status |
NCT01010607 |
Phase 1, Phase 2 |
|
15 |
A Phase 2 Study of HC-58 in Patients With Severe Upper Limb Hemiplegia After Stroke |
Completed |
NCT01623622 |
Phase 2 |
HC-58;Placebo |
16 |
Single-center Phase I/II Trial of Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO Trial) |
Completed |
NCT00931164 |
Phase 1, Phase 2 |
Sodium Oxybate |
17 |
Auditory Rhythm Cues + Task Practice: Effects on UE Motor Function Post-stroke |
Completed |
NCT00523523 |
Phase 1, Phase 2 |
|
18 |
Subacute Stroke Recovery (Upper Extremity Motor Function): Bimanual Coordination Training |
Completed |
NCT00369668 |
Phase 2 |
|
19 |
Contralaterally Controlled Functional Electrical Stimulation for Hemiparetic Hand |
Completed |
NCT00565045 |
Phase 1, Phase 2 |
|
20 |
"Etude Pilote, Comparative, Monocentrique, randomisée, en Cross Over, en Double Aveugle, Contre Placebo, Testant l'efficacité de l'Huile triheptanoïne Dans Les Hémiplégies Alternantes de l'Enfant" HEMIHEP |
Completed |
NCT02408354 |
Phase 2 |
Triheptanoin;Placebo |
21 |
Low Intensity Physical Activity Leads to Improvement in Brachial-ankle Pulse Wave Velocity in the Affected Leg of Hemiplegics |
Completed |
NCT01569386 |
Phase 2 |
|
22 |
Pediatric Hemiplegia: Synergistic Treatment Using rTMS and CIT |
Completed |
NCT01104064 |
Phase 1 |
|
23 |
Optimizing Hand Rehabilitation Post-Stroke Using Interactive Virtual Environments |
Completed |
NCT01072461 |
Phase 1 |
|
24 |
Different Dilutions and Efficacy of Botulin Toxin in the Correction of the Hemiplegic Gait |
Recruiting |
NCT04630873 |
Phase 1 |
Botulinum toxin |
25 |
Efficacy of Transcranial Laser Therapy for Improving Upper Extremity Functional Recovery in Hemiplegic Patients From Ischemic Stroke |
Terminated |
NCT01308216 |
Phase 1 |
|
26 |
National Egyptian Network Pediatric Stroke and Hemiplegia Registry |
Unknown status |
NCT02129491 |
|
|
27 |
Short-Term Effects of Whole-Body Vibration on Upper Extremity Function in Subjects With Poststroke Hemiplegia |
Unknown status |
NCT03963258 |
|
|
28 |
The Effects of Proximal And Distal Tibiofibular Joint Manipulations on Foot Posture, Ankle Range of Motion, and Balance in Chronic Hemiplegic Individuals |
Unknown status |
NCT04178369 |
|
|
29 |
Effects of Infant Constraint Induced Movement Therapy and Infant Bimanual Intensive Therapy in Unilateral Cerebral Palsy. A Randomized Controlled Trial. |
Unknown status |
NCT04642872 |
|
|
30 |
Neuromuscular Electrical Stimulation (NMES) Applied to Back Extensors in Stroke Patients; Effects on Functional Capacity and Mobility |
Unknown status |
NCT03811106 |
|
|
31 |
Early Effects of Trunk Kinesio Taping on Balance and Functional Performance in Patients With Acute Stroke |
Unknown status |
NCT04105322 |
|
|
32 |
Reliability of Rehabilitative Ultrasound Imaging for the Quadriceps Muscle and Sarcopenia in Poststroke Patients |
Unknown status |
NCT04042818 |
|
|
33 |
Morbidity Prevalence Estimate at Six Months Following a Stroke: A Cohort Study. |
Unknown status |
NCT03605381 |
|
|
34 |
Reliability of Kinematic Analysis in Assessment and Rehabilitation of the Upper Arm of Stroke Patients Following a Cerebral Vascular Accident, Hemiparetic Subjects |
Unknown status |
NCT02326688 |
|
|
35 |
The Use of Ultrasound for Botulinum Toxin Subscapularis Muscle Injection Guidance in Spastic Hemiplegic Shoulder Pain |
Unknown status |
NCT03621423 |
|
|
36 |
Tele-rehabilitation in the Home With Gaming as a Method of Improving Upper Extremity Function After Stroke |
Unknown status |
NCT02494362 |
|
|
37 |
Cardiopulmonary Rehabilitation in Chronic Stroke Patients |
Unknown status |
NCT03558542 |
|
|
38 |
Cardiovascular Function in Sub Maximal Exercise and Performance in Three Daily Activity Tests in Persons With Post Stroke Conditions |
Unknown status |
NCT01396746 |
|
|
39 |
A Multi-site, Interventional, Non-comparative, Single-arm Trial to Evaluate the Safety of the ReWalk ReStore Device in Subjects With Mobility Impairments Due to Ischemic or Hemorrhagic Stroke |
Unknown status |
NCT03499210 |
|
|
40 |
A Clinical Observational Follow-up Study of European Pediatric Cases of Acute Flaccid Myelitis Associated With EV-D68 Infection. |
Unknown status |
NCT03499366 |
|
|
41 |
Constraint Induced Movement Therapy (CIMT) in Babies Home Program |
Unknown status |
NCT01214902 |
|
|
42 |
Study on the Effectiveness of Action Observation Treatment (AOT) as a Rehabilitation Tool in Acute Stroke Patients and in Chronic Stroke Patients With Apraxia: a Randomized Controlled Trial |
Unknown status |
NCT02235350 |
|
|
43 |
The Effect of Combined Armeospring Pediatric and Constraint Induced Therapy on Neuro-motor and Functional Recovery in Children With Unilateral Cerebral Palsy |
Unknown status |
NCT02914925 |
|
|
44 |
Scalp Acupuncture for Motor Dysfunction in Ischemic Stroke: a Randomized, Controlled Trial |
Unknown status |
NCT02871453 |
|
|
45 |
Immersive Virtual Reality for Visuo-motor Integration Skill Assessment in Children With Hemiplegia |
Completed |
NCT04612049 |
|
|
46 |
The Effects of the Swiss Ball on Patients With Hemiplegia Due to Cerebral Vascular Accident |
Completed |
NCT00735033 |
|
|
47 |
Immediate Effect of Cervical Posterior Muscles' and Gluteus Medius Muscle's Vibrations on Gait in Chronic Vascular Hemiplegia |
Completed |
NCT02096367 |
|
|
48 |
Action-Observation Therapy (AOT) and Information and Communications Technologies (ICT) for Home Rehabilitation of Hemiplegia |
Completed |
NCT03094455 |
|
|
49 |
Does Transcranial Direct Current Stimulation Affect Selective Visual Attention in Children With Left-sided Infantile Hemiplegia? A Preliminary Randomized Controlled Study |
Completed |
NCT04278430 |
|
|
50 |
Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months). |
Completed |
NCT04187209 |
|
|
Cochrane evidence based reviews: hemiplegia
|